Bolt Biotherapeutics
PublicBolt Biotherapeutics is now publicly traded
The data on this page reflects Bolt Biotherapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Feb 5, 2021
Last Round
Private Placement
Jun 1, 2021
Total Funding Raised
$463.39M
Company Overview
Bolt Biotherapeutics is a clinical-stage biopharmaceutical company that develops novel immunotherapies for the treatment of cancer using its proprietary Boltbody™ Immune-Stimulating Antibody Conjugate (ISAC) platform.
Sector
Biotech
AI Layer
Non-AI
Keywords
Bolt Biotherapeutics Comparables
Compare Bolt Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Seven and Eight Biopharmaceuticals Inc. | 77% | |
| Ankyra Therapeutics | 76% | |
| Nammi Therapeutics | 73% |
For institutional investors. Book with your work email.
Bolt Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Jun 1, 2021 | ||||
| IPO | Feb 5, 2021 | ||||
| Series C | Jul 1, 2020 | ||||
| Series B | Feb 5, 2019 | ||||
| Private Placement | Jul 26, 2018 | ||||
Private Placement | Feb 14, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bolt Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series C |
| RA Capital Management | Series C |
| Nan Fung Life Sciences | Series B |
| Novo Holdings | Series C, Series B, Series A |
| Pivotal bioVenture Partners | Series C, Series B |
| Samsara BioCapital | Series C |
| Rock Springs Capital | Series C |
For institutional investors. Book with your work email.
Bolt Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.